The QualityStocks Daily Monday, October 8th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (IGC) +66.42%

NetworkNewsWire (TVTV) +62.50%

Small Cap Firm (CLDC) +61.23%

The QualityStocks Daily Stock List

International Frontier Resources Corporation (IFRTF)

MarketWatch, Stockhouse, Marketwired, 4-Traders, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources is based in Calgary, Alberta. The Company lists on the OTC Markets Group’s OTCQB.

International Frontier Resources (IFR) has projects in the U.S. and Canada. This includes the State of Montana and the Northwest Territories.

IFR created a JV company in 2015 - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are totally aligned; each owns a 50 percent stake in Tonalli. Grupo Idesa is a well-established Mexican petrochemical company.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators’ in Mexico. In addition, it provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with major upside potential.

The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz. The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or about 7,700 feet. The Tecolutla Block is a 60-80 m gross pay carbonate reservoir on a structural high with proven oil production.

Tonalli has submitted the regulatory applications and documentation, which will permit IFR to go ahead with the drilling permit and operations at Tecolutla. The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

On May 8, 2018, Tonalli started a production test of the TEC-2 well producing from existing perforations. This well was tested for seven days and recovered an average of 125 barrels of oil per day (bopd).  Last recorded production rate in January 2016 from TEC-2 was 9 bopd and 9 thousand cubic feet (mcf) of natural gas per day.

Over the final day of the test, the TEC-2 well averaged an estimated 105 bopd and 288 mcf of gas producing 514 bbls/d of fluid. Throughout the test, TEC-2 flowed naturally on a restricted 20/64 inch well head choke. A final wellhead flowing pressure was 660 psig.  The ratios of crude oil, water, and natural gas remained consistent throughout the multi-day test.

Yesterday, IFR announced the appointment of a new independent Director, Mr. R. Glenn Dawson to its Board. Mr. Dawson brings 38 years of oil and gas exploration and management experience in the North American hydrocarbon basins to IFR’s Board of Directors. Mr. Dawson has founded a number of publicly traded oil and gas companies. He has been responsible for exploration and production (E&P) budgets of more than CDN$200 million annually.

International Frontier Resources Corporation (IFRTF), closed Monday's trading session at $0.1042, down 7.13%, on 35,899 volume with 8 trades. The average volume for the last 3 months is 60,915 and the stock's 52-week low/high is $0.078/$0.287.


Nutritional High International, Inc. (SPLIF)

SmallCapVoice, CFN Media Group, Promotion Stock Secrets, and News reported on Nutritional High International, Inc. (SPLIF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Nutritional High International, Inc. centers on developing, manufacturing, and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries. These include edibles and oil extracts for nutritional, medical, and adult recreational use. The Company works exclusively via licensed facilities in jurisdictions where such activity is permitted and regulated by state law. Nutritional High International is based in Toronto, Ontario.

Concerning its Hemp-Infused Products segment, Nutritional High International launched the first product in its Active Hemp category under the brand of “Nutritional Traditions”. For this segment, initial distribution will focus on California and Colorado through cannabis-related retail stores: medical marijuana dispensaries, vape lounges and headshops; and Food Supplement retail stores.

Regarding its Marijuana-Infused Products segment, Nutritional High concentrates on developing, acquiring, and designing Marijuana-Infused Products (MIPs) and Marijuana Concentrate products and brands. With this segment, the Company is establishing operations in Colorado and Illinois. It is working to expand into more U.S. States in support of its strategy to establish some of the first nationally-recognized brands for MIPs.

Nutritional High entered into an agreement to acquire the technology and Intellectual Property (IP) rights to a unique product to be referred to as the “Dab Stick”. The Dab Stick is a dispenser for viscous liquid substances. It can carry roughly 1⁄2 gram of cannabis oil extract designed with the retail consumer and adult use user in mind.

Nutritional High International announced this past March that it entered into a non-binding Letter of Intent (LOI) to acquire a 75 percent interest in Green Therapeutics LLC. Green Therapeutics is one of the premier innovators and established producer/processors within the cannabis space in Nevada.

Recently, NeutriSci International, Inc. and Nutritional High International announced the entry into a binding Memorandum of Understanding (MOU) to develop, manufacture, and distribute THC and CBD infused sublingual tablets employing NeutriSci’s patent pending technology, proprietary ingredients and formulations. NeutriSci is the innovator and pioneer behind neuenergy.

NeutriSci and Nutritional High (subject to the negotiation of a definitive agreement) will develop products that will be manufactured and distributed by Nutritional High in U.S. States that allow the sale of cannabis infused products. The tablets will combine the benefits of NeutriSci and Nutritional High’s existing technologies and ingredient mixes.

Nutritional High International has signed a definitive agreement for the acquisition of Pasa Verde, a commercial scale cannabis oil extraction and edible facility in Sacramento, California. Pasa Verde produces several extract products on a contract manufacturing basis for top brands. It will start producing Nutritional High's FLÏ™ branded oil and edible products.

Last week, Nutritional High International announced its entry into a Letter of Intent (LOI) to acquire a 51 percent interest in Bright Green Lights LLC, a California company (d/b/a as J:MEDS). J:MEDS produces high quality cannabis-infused strain specific lozenges and sugar-free mints distributed throughout California. Nutritional High believes that its subsidiary Calyx Brands can substantially build sales of J:MEDS products. J:MEDS is a pioneer of “microdosed” infused products. It is one of California’s longest operating and most respected edible companies.

Nutritional High International, Inc. (SPLIF), closed Monday's trading session at $0.251, up 4.85%, on 78,150 volume with 28 trades. The average volume for the last 3 months is 169,753 and the stock's 52-week low/high is $0.0879/$0.9419.


BioCardia, Inc. (BCDA)

TradingView, Insider Financial, Stockopedia, Marketbeat, InvestingNote, and MarketWatch reported on BioCardia, Inc. (BCDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioCardia, Inc. is a leader in the development of total solutions for cardiovascular regenerative therapies. The Company’s biotherapeutic product candidates in clinical development are CardiAMP® (autologous minimally processed bone marrow cells [a patient’s own cells]) and CardiALLO® (allogenic culture expanded mesenchymal stem cells derived from bone marrow [donor-derived]) cell therapies. A clinical-stage regenerative medicine company, BioCardia is based in San Carlos, California.

BioCardia’s two therapeutic programs are enabled by its Helix™ transendocardial delivery systems and Morph® vascular access products that are partnered to enable other promising biotherapeutic programs. Also, the Helix transendocardial delivery system is being used by a number of clinical partners in biotherapeutic clinical trials.

The Helix transendocardial delivery system is the leading percutaneous catheter delivery system for cardiovascular regenerative medicine. Helix enables the local delivery of cell and gene-based therapies to treat heart failure, myocardial infarction, ischemia, as well as cardiac conduction disorders.

The Company’s CardiALLO uses younger universal donor mesenchymal stem cells. BioCardia states that CardiALLO may be suitable for patients who are not optimal candidates for the CardiAMP therapy.

CardiAMP harnesses the potential of autologous minimally processed bone marrow cells, using a companion diagnostic to identify patients most likely to benefit from the therapy. The design of the investigational CardiAMP cell therapy system is to deliver a high dose of a patient’s own bone marrow cells directly to the area of cardiac dysfunction to stimulate the body’s natural healing mechanism after a heart attack.

BioCardia announced in January 2018 that the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with refractory angina (RA).

The CardiAMP Chronic Myocardial Ischemia Trial will be a prospective, multi-center, randomized, sham-controlled, patient- and evaluator-blinded pivotal trial. The trial is to validate the safety and efficacy of CardiAMP investigational cell therapy in the treatment of patients having CMI with RA.

The CardiAMP Heart Failure Trial is presently enrolling patients at 13 world class centers in the U.S. with Center for Medicare and Medicaid Services (CMS) National Reimbursement.  The trial design was published in the American Heart Journal in April of this year.

BioCardia received a new US Patent related to its CardiAMP cell potency assay. This provides further protection to the Company’s autologous cell therapy programs in heart failure and chronic myocardial ischemia indications.

On April 25, 2018, BioCardia announced the issuance of United States Patent No. 9,945,854 relating to methods of measuring therapeutic potency potential and defining dosages for autologous cell therapy.

In May, BioCardia announced that the Centers for Medicare and Medicaid Services (CMS) approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.

BioCardia, Inc. (BCDA), closed Monday's trading session at $2.75, up 1.85%, on 1,989 volume with 8 trades. The average volume for the last 3 months is 9,254 and the stock's 52-week low/high is $1.124/$5.64.


MYnd Analytics, Inc. (MYND)

Stock Twits, Talk Traders, OTC Markets, The Street, Business Insider, Bzweekly, Zacks, Equity Clock, Capital Cube, Simply Wall St, 4-Traders, Barchart, BioSpace, MarketWatch, Marketbeat, GuruFocus and Street Insider reported on MYnd Analytics, Inc. (MYND), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MYnd Analytics, Inc. is a market leader in reducing costs and improving the delivery of mental health services via the combination of telemedicine and data analytics/artificial (augmented) intelligence. MYnd brings objective physical findings to psychiatric treatment to lessen trial and error treatment in mental health. The Company provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. A predictive medicine company, MYnd Analytics has its corporate office in Mission Viejo, California.

MYnd has its Psychiatric EEG Evaluation Registry, or PEER Online®. The goal of PEER Online is to provide objective, personalized data to help physicians in the selection of suitable medications. PEER Online is a cloud-based platform. It is a registry and reporting platform. PEER Online enables medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG).

PEER combines a "crowdsourced" secure physician outcome registry with electroencephalogram (EEG). EEG is an accepted, well-normed test of brain function. EEG is a completely painless, non-invasive test. It records one’s brain’s electrical activity.

Moreover, the Company has its MYnd Analytics Center. The Center provides a convenient, relaxing, and welcoming environment for one to receive their EEG and PEER Report™. The EEG is performed on-site at the MYnd Analytics Center. Physicians who use PEER decrease trial and error re-scribing.

MYnd Analytics continues to integrate its recently acquired Arcadian Telepsychiatry Services LLC business into its legacy business. MYnd Analytics earlier announced that its wholly-owned subsidiary, Arcadian Telepsychiatry Services launched a new program to offer, by way of its network of Providers, youths in rural, suburban and urban markets with school-based access to telepsychiatry, teletherapy and other mental health services.

Telepsychiatry involves the use of video conferencing equipment to conduct real time mental health consultations between a clinician and a patient. The design of the program is to benefit children and teenagers across the nation, especially those with limited access to mental health services.

In September, MYnd Analytics announced that the U.S. Food & Drug Administration (FDA) granted Breakthrough Device designation for MYnd’s next generation product PEER 4.0. Under the Breakthrough Devices program (a provision of the 21st Century Cures Act) the FDA works with medical device developers to accelerate regulatory review for diagnostic and therapeutic technologies, which address a critical unmet need or a serious condition, where preliminary clinical evidence indicates significant improvement versus the present standard of care.

Additionally, in September, MYnd Analytics announced that its wholly-owned subsidiary, Arcadian Telepsychiatry Services LLC, has partnered with Integrated Behavioral Health, Inc. (IBH) to provide TeleEAP services to IBH’s members. IBH is a pioneer in managed behavioral health and integrated employee assistance programs and services. At present, IBH (Costa Mesa, California) serves greater than 7 million members, representing 26,000 individual clients across the U.S.

MYnd Analytics, Inc. (MYND), closed Monday's trading session at $1.38, down 8.61%, on 122,275 volume with 269 trades. The average volume for the last 3 months is 464,531 and the stock's 52-week low/high is $1.149/$4.29.


Applied BioSciences Corp. (APPB)

Stockhouse, OTC Markets, Penny Stock Hub, InvestorsHub, Daily Marijuana Observer, Simply Wall St, TradingView, Investors Hangout, Stockopedia, and The Stock Market Watch reported on Applied BioSciences Corp. (APPB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Applied BioSciences Corp. is a diversified cannabinoid therapeutics company. It concentrates on the medical, bioceutical and pet health industries. The Company was previously known as Stony Hill Corp. Applied BioSciences has its corporate office in Beverly Hills, California. The Company lists on the OTC Markets Group’s OTCQB.

Applied BioSciences focus is on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceuticals and media industries. The Company’s products include Remedi CBD and TherPet.

Applied BioSciences uses organic ingredients and formulations created to target common ailments in the health and wellness industry for anyone who is open to trying hemp derived products. These products use industrial hemp as an input to produce high quality CBD for an array of health and wellness products.

Remedi CBD is a line of premium hemp-derived CBD products. These products include topicals, gummies, and more. The Company has expanded its product line and launched a hemp-derived CBD product line under the Remedi CBD brand. In addition, Applied BioSciences has commenced sales of its hemp-derived CBD products on LeafLink's industry-leading B2B (Business-to-Business) e-commerce platform.

Applied BioSciences’ wholly-owned animal health subsidiary is TherPet. It has entered the equine health market with the launch of a new full-spectrum hemp-derived cannabidiol (CBD) supplement formulated specifically for a horse's health and wellness. TherPet's Equine Care CBD line is a natural supplement.

Applied BioSciences announced this past June that it entered into a marketing and distribution agreement with CanaGel™ to launch their first patent-protected product, Hemp Oil Gel Melts. Applied BioSciences adds the patented CanaGel™ Hemp Oil Gel Melts to its extensive group of product offerings. The Company will leverage its North American and European marketing and distribution channels to assist CanaGel™ in launching its first doctor-developed product.

Independent lab tests show that after 2.5 minutes of contact, 80 percent of Phytocannabinoids were absorbed in vitro. After 5 minutes, virtually 100 percent of the nutrient-rich Phytocannabinoids were absorbed in vitro.

Applied BioSciences Corp. (APPB), closed Monday's trading session at $2.20, down 25.17%, on 1,825 volume with 10 trades. The average volume for the last 3 months is 1,410 and the stock's 52-week low/high is $1.00/$3.50.


Katanga Mining Limited (KATFF)

OTC Markets, Stockwolf, Insider Financial, Stockhouse, 24hGold, The Street, InvestorsHub, 4-Traders, and Stockwatch reported on Katanga Mining Limited (KATFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Katanga Mining Limited, by way of its subsidiary, Kamoto Copper Company SA, engages in copper and cobalt mining and related activities in the Democratic Republic of Congo (DRC). The Company operates a large-scale copper-cobalt project with substantial high-grade mineral reserves and integrated metallurgical operations in the DRC. Katanga Mining is based in Whitehorse, Yukon Territory and also has offices in Zug, Switzerland, and Johannesburg, South Africa.

The Company operates a large-scale copper-cobalt mine complex in the DRC through two joint ventures (JVs). These are Kamoto Copper Company (KCC) and DRC Copper and Cobalt Project (DCP). Katanga Mining’s assets include the Kamoto Underground Mine and KOV open pit mine. These provide sulfide and oxide ores, respectively.

In addition, Katanga Mining’s assets include the Kamoto Concentrator and Luilu Metallurgical Plant for the onsite production of refined copper and cobalt. The Company also has a number of other mines and plants. The Kamoto Project commenced commercial production on June 1, 2008.

For this year, Katanga Mining’s production guidance is 150,000 tonnes and 11,000 tonnes of copper cathode and cobalt contained in hydroxide, respectively.

Katanga Mining was notified on April 20, 2018 that its JV partner, the Democratic Republic of Congo (DRC) state-owned La Générale des Carrières et des Mines (Gécamines), in the Company’s 75 percent DRC operating subsidiary Kamoto Copper Company (KCC), started legal proceedings in the DRC to dissolve KCC.

This is following KCC’s failure to address its earlier disclosed capital deficiency or, alternatively, if the Court provides KCC with a period of time within which to regularize the situation, to request the appointment of an expert to assess and report to the Court on KCC’s financial position and the recapitalization plan. Katanga Mining believes that it has several options to resolve KCC’s capital deficiency and avoid KCC’s dissolution.

Katanga Mining announced that Ventora Development Sasu, a company affiliated with Mr. Dan Gertler, on April 27, 2018, served in the DRC a freezing order against Kamoto Copper Company (KCC) in the amount of US$2.28 billion.

The freezing order authorizes the bailiff of the Commercial Court of Kolwezi to freeze certain bank accounts, tangible movable assets, and intangible movable assets, including receivables of KCC, and the mining titles, up to the amount of the freezing order and prevent KCC from disposing and/or utilizing these assets.

Katanga Mining Limited (KATFF), closed Monday's trading session at $0.52, up 1.07%, on 10,139 volume with 13 trades. The average volume for the last 3 months is 148,593 and the stock's 52-week low/high is $0.472/$2.25.


Village Farms International, Inc. (VFFIF)

Small Cap Exclusive, Stockwatch, Stockhouse, Midas Letter, Cannabis Daily, Street Insider, Investor Network, Business Insider, 4-Traders, OTC Markets, TradingView, Barchart,, WalletInvestor, New Cannabis Ventures, YCharts, CapitalCube, and Daily Marijuana Observer reported on Village Farms International, Inc. (VFFIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Village Farms International, Inc. is one of the largest producers of premium quality greenhouse tomatoes, bell peppers, and cucumbers in North America. The Company is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. OTCQX-listed, Village Farms International has its headquarters in Delta, British Columbia. Its U.S. corporate office is in Heathrow, Florida.

Village Farms International’s vegetables are grown hydroponically in a glass enclosed high technology environment employing sophisticated computer systems to control irrigation, fertilizers, carbon dioxide, light, temperature, ventilation, humidity and other climatic factors. The Company’s greenhouse vegetables are produced by plants that are not genetically modified.

Village Farms International produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the United States and Canada. The Company does so from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia (B.C.) and Texas and from its partner greenhouses in B.C., Ontario, and Mexico.

Village Farms International also markets, provides technical support, and logistics services for more than 200 acres of greenhouse production across the United States, Canada, and Mexico. The Company’s products are marketed and distributed under its Village Farms® brand name, chiefly to retail supermarkets and dedicated fresh food distribution companies.

Village Farms International is positioned to enter the cannabis industry. The Company is unique in the Canadian cannabis arena. It already has fully scaled-up greenhouse operations that grow the aforementioned premium quality produce. The Company sells to North America’s foremost grocers.

At the end of April, Village Farms International announced that its 50/50 joint venture (JV) with Emerald Health Therapeutics, Inc., Pure Sunfarms Corp., entered into a supply agreement with Emerald. With this agreement, Emerald Health Therapeutics will purchase 40 percent of Pure Sunfarms' production in 2018 and 2019, or roughly 21,000 to 24,000 kilograms using present projected production targets, at a pre-determined price per gram.

Mr. Michael DeGiglio, Director, Pure Sunfarms, and Chief Executive Officer, Village Farms International, said, "We are confident Pure Sunfarms' unmatched experience in large-scale, low-cost agricultural production and fulfilling regular, large-volume supply commitments at consistent quality, alongside extensive cannabis expertise and significant scale, will place it in the top tier of Canadian and international cannabis growers and downstream product developers."

At the beginning of June, Village Farms International announced that it entered into a new, exclusive, seven-year agreement to sell, market, and distribute the Company’s exclusive tomato varieties grown by Mexico-based Agroparque de Yecapixtla.  The new agreement extends the existing agreement between the two companies, under which Agroparque de Yecapixtla grows tomato varieties for Village Farms International, including Village Farms' exclusive specialty varieties that undergo distribution under the Village Farms brand.

Village Farms International, Inc. (VFFIF), closed Monday's trading session at $5.24, up 3.18%, on 189,884 volume with 340 trades. The average volume for the last 3 months is 20,481 and the stock's 52-week low/high is $2.25/$7.81.


Wize Pharma, Inc. (WIZP)

Dividend Investor, Penny Stock Hub, Stockhouse, InvestorsHub, Wallmine, OTC Markets, Barchart, MarketWatch, Stockwatch, Cardinal Weekly, Investors Hangout, InsiderMole, Stockopedia, 4-Traders, and CapitalCube reported on Wize Pharma, Inc. (WIZP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Wize Pharma, Inc. concentrates on the treatment of ophthalmic disorders. This includes dry eye syndrome (DES). The Company formerly went by the name Star Night Technologies Ltd. It changed its name to Wize Pharma, Inc. in July 2015. A clinical-stage biopharmaceutical enterprise, the Company is based in Hod Hasharon, Israel. Wize Pharma’s shares trade on the OTCQB.

Wize Pharma has in-licensed certain rights to purchase, market, sell, as well as distribute a formula called LO2A. This is a drug developed for the treatment of DES, and other ophthalmological illnesses, including conjunctivochalasis (CCH) and Sjögren's Syndrome. LO2A is presently registered and marketed by its inventor in Germany and Switzerland for the treatment of DES, in Hungary for the treatment of DES and CCH, and in the Netherlands for the treatment of DES and Sjögren's Syndrome.

Wize Pharma is now conducting a Phase II trial of LO2A for patients with CCH and a Phase IV study for LO2A for DES in patients with Sjögren's. The Company announced in March 2018 that it enrolled the initial patient in its Phase IV clinical trial in Israel for LO2A in the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome.

The randomized, double-masked study is evaluating LO2A versus Alcon's Systane® Ultra UD, an over-the-counter (OTC) lubricant eye drop product used to relieve dry and irritated eyes. The design of the study (in addition to meeting marketing approval requirements in Israel) is to support Wize’s clinical approval pathway for LO2A for the treatment of DES in patients with Sjögren's in other markets including the United States, China, and Ukraine. LO2A is already approved in Israel for the treatment of DES.

This past June, Wize Pharma announced that it signed an exclusive distribution agreement with HPGC Medical Co., Ltd. (HPGC) for the distribution in China by HPGC of LO2A. HPGC is a division of Harbin Pharmaceutical Group Co. Ltd. Harbin Pharmaceutical Group is one of China's largest healthcare companies with 20,000 employees and assets worth $2.9 billion.

Last month, Wize Pharma announced the appointment of Ms. Ellen A. Lubman to its Advisory Board. Ms. Lubman is a biotechnology executive specializing in business development, asset acquisitions and strategic partnering. She will serve as a strategic advisor to the Company’s senior Management and Board of Directors. Most recently, Ms. Lubman was at Allergan. At Allergan, she served as Vice President, External Science & Innovation.

Wize Pharma, Inc. (WIZP), closed Monday's trading session at $1.75, down 11.62%, on 1,473 volume with 8 trades. The average volume for the last 3 months is 2,490 and the stock's 52-week low/high is $0.779/$10.80.



Wallstreet Profiler, RedChip, PennyDoctor, ProfitableTrading, Investors Alley, and Street Authority Daily reported earlier on QPAGOS Corp. (QPAG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

QPAGOS Corp. is a provider of digital payment services for cash based and unbanked consumers in Mexico. It operates a network of self-service kiosks and applications designed to provide more convenient payment alternatives for consumers and more efficient billing for service providers. QPAGOS is based in Mexico City, Mexico.

QPAGOS has its state-of-the-art electronic payments technology. This technology provides users with a convenient and secure alternative for paying bills, products and services, using numerous devices. These include self-service kiosks, mobile, and Personal Computer (PC)-based applications.

For advertisers, QPAGOS provides a new channel to attract business and interact with customers. QPAGOS self-service kiosks have an integrated second screen to broadcast advertising spots and messages. For QPAGOS users, there is no more waiting in line or trying to find a remote location to make frequent payments.

For service providers, QPAGOS contributes to broaden their national collections footprint. This is while decreasing transactional costs. For the Company’s distributors and franchisees, QPAGOS provides a very appealing income source as they can monetize high traffic physical spaces.

QPAGOS has a broad portfolio of service providers and retailers that receive payments via its kiosks. These include utilities, cellphone operators, entertainment, as well as banking services.

QPAGOS has a strong processing platform. The Company is working to capitalize on the unbanked alternative market. It is targeting the large Latin American market with a main focus on Mexico. It is doing so through the steady rollout of its user-friendly bill payment kiosks and software.

QPAGOS and DPW Holdings, Inc., a diversified holding company, announced this month the execution of an agreement to form a new joint venture (JV) for launching a network of 1,000 self-service kiosks beginning in California over the next year. The expectation is that the parties will enter into an operating agreement of Innovative e-Payment Solutions, LLC and related credit facility agreement and supply agreement, on or before July 1, 2018.

Unless otherwise agreed to by the parties, the agreement to form a JV will end if the parties do not enter into the operating agreement, credit facility agreement and supply agreement before July 1, 2018. Last week, QPAGOS announced that it chose Crane Payment Innovations (CPI), the international leader in providing cash payment solutions and a Crane Co. company, to integrate CPI’s cash management technology into QPAGOS kiosks to be deployed in its JV Innovative e-Payment Solutions, LLC.

In addition, last week, QPAGOS announced it has partnered with Instituto del Deporte y la Recreación del Estado de Queretaro (INDEREQ), to deploy self-service kiosks and accept payments for INDEREQ members in the State of Queretaro, Mexico. INDEREQ was created as an independent public entity of the State of Queretaro. It has the mission of promoting and sponsoring sports in the State of Queretaro. Three of five initial QPAGOS self-service kiosks have already been installed at INDEREQ facilities.

QPAGOS Corp. (QPAG), closed Monday's trading session at $0.23, up 13.88%, on 84,541 volume with 32 trades. The average volume for the last 3 months is 7,745 and the stock's 52-week low/high is $0.079/$0.60.


Monarques Gold Corporation (MRQRF)

The National Investor, 24hgold, Northern Miner, Private Capital News Wire, Stockhouse, Northern Vertex, Canadian Insider, Barchart, Junior Mining Network, 4-Traders, Mining & Energy, and YCharts reported on Monarques Gold Corporation (MRQRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Monarques Gold Corporation is an emerging gold producer listed on the OTC Markets. Its emphasis is on pursuing growth via its large portfolio of high-quality projects in the Abitibi mining camp in Quebec. The Company previously went by the name Monarques Resources, Inc. It changed its corporate name to Monarques Gold Corporation in January of 2015. Monarques Gold has its head office in Montreal, Quebec.

Monarques owns close to 300 km² of gold properties. These include the Beaufor Mine, the Croinor Gold, Wasamac, McKenzie Break and Swanson advanced projects. Additionally, it owns the Camflo and Beacon mills, and six promising exploration projects. Monarques Gold also offers custom milling services out of its 1,600 tonne-per-day Camflo mill.

The Beaufor Mine had production of 5,444 ounces of gold in Q2 2018. This represents an increase of 61 percent since its acquisition from Richmont Mines. Annual production at Beaufor is +20K ounces. The Beaufor Mine has strong drilling results. This includes 61.48 g/t Au over 3.9 m. There is excellent potential to boost the resource at Beaufor.

Monarques Gold announced this past July that it filed on SEDAR a National Instrument 43-101 technical report for its McKenzie Break gold project. In early August, Monarques announced that it filed on SEDAR a National Instrument 43-101 technical report for its Swanson gold project.

Last week, Monarques Gold reported additional assay results from the 2018 diamond drilling program at its wholly-owned Croinor Gold project 50 kilometers east of Val-d'Or , Quebec. The initial 20,000-meter program began in March of this year and centered on the expansion and infilling of the Croinor Gold deposit. The program completed in early September with 19,935 meters of core drilled in 89 holes. Drilling continued with one rig on the property; a second drill was added on September 17th to drill an additional 8,300 meters before the winter freeze.

In addition, last week, Monarques Gold announced that it acquired a 2 percent Net Smelter Royalty (NSR) on the Chimo-Boyd claims in exchange for the issuance of 170,000 common shares of Monarques at a price of $0.28 per share and a cash payment of $8,400. On September 10, 2018, the Company announced the sale of its remaining interest in the Chimo property (including the Chimo-Boyd claims) to Chalice Gold Mines Ltd.

Jean-Marc Lacoste, President and Chief Executive Officer of Monarques Gold, said, "With this transaction, we now hold a 2.5 percent NSR on almost all of the 73 claims forming the Chimo property, with the exception of a few claims for which we hold a 0.5 percent NSR. If the property were ever to go into production, we would be able to reap the benefits of this investment at a more than reasonable cost."

Monarques Gold Corporation (MRQRF), closed Monday's trading session at $0.15187, up 6.80%, on 96,900 volume with 9 trades. The average volume for the last 3 months is 22,962 and the stock's 52-week low/high is $0.108/$0.349.


Maple Gold Mines Ltd. (MGMLF)

Jet Life Penny Stocks, Dividend Investor, Wallet Investor, InvestorsHub, GuruFocus, MarketWatch, Wall Street Nation, OTC Markets, Stockwatch, Stockhouse, 4-Traders, Junior Mining Network, TradingView, Barchart, and InvestorsHangout reported earlier on Maple Gold Mines Ltd. (MGMLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Maple Gold Mines Ltd. is an exploration company focused on advancing a district-scale gold project in one of the world’s premier mining jurisdictions. The Company’s 370 km2 Douay Gold Project is within the prolific Abitibi Greenstone Belt in northern Quebec. The Douay Gold Project has excellent infrastructure with large operating mines within 150 kms. There is significant resource expansion and exploration upside at the Douay Gold Project.

OTCQB-listed, Maple Gold Mines has its management office in Toronto, Ontario. The Company formerly went by the name Aurvista Gold Corporation. It changed its name to Maple Gold Mines Ltd. in November 2017.

The Douay Project has an established gold resource that remains open in numerous directions. Maple Gold is focusing on expanding the known resource areas and testing new discovery targets within its 55 km of strike along the Casa Berardi Deformation Zone.

The updated resource estimate (NI 43-101 Technical Report - March 2018) successfully converted a major proportion of Inferred to the Indicated Resource category, at Douay West and Porphyry Zones. Resources at Douay now stand at 2.76 million ounces Inferred plus 0.48 million ounces Indicated.

This past July, Maple Gold Mines reported the final drill results from the NW Gap Area - the area between the NW, Douay West and Porphyry Zones that includes the new Nika Zones. There were a select number of historical drill-holes drilled in the NW Gap Area from 2011 to 2017 inclusive by Aurvista Gold (now Maple Gold Mines). However, because of the limited drill density, the area represented a high-priority target for new discoveries and potential extensions of existing zones outside the presently established conceptual pits (Micon 2018). Within this area, 12 holes were drilled this year, with the majority spaced from 100 up to 300 meters from the nearest pre-existing drill collar.

Mr. Fred Speidel, Maple Gold Mines’ Vice President Exploration,  stated: "Assays for the NW Gap Area, including the promising new Nika Zones, are now complete. These additional results demonstrate that gold mineralization in the Nika Zones, part of which is well above deposit average grade, widens significantly towards the west and locally remains open up-dip and down-dip."

In September, will all assays being received, Maple Gold Mines provided a highlights summary of the 2018 drilling campaign. The 2018 winter drilling campaign included 21,122 meters of diamond drilling from 52 holes and 1,471.3 meters from 57 short top-of-bedrock Reverse Circulation (RC) holes for a total of 22,593 meters.

The assay results from drilling in the central part of the Porphyry Zone (including DO-18-216) support Maple Gold’s concept of manifold higher-grade zones or shoots within the Porphyry Zone. The assay results also demonstrate the continuity of this style of mineralization in the central part of the Porphyry Zone and open the possibility of increasing grades at depth.

Highlighted results from the east-central part of the Porphyry Zone (DO-18-247, DO-18-254 and DO-18-244) targeted an area with lower drill density and intersected appreciably higher grades than neighboring holes. This indicates that grade may increase at depth in this area.

Furthermore, drilling in the western half of the Porphyry Zone (west of DO-18-216) confirmed the presence of a broad (90- to 130-meter true width) halo of gold mineralization, extending several hundred meters along strike and primarily hosted in syenites (DO-18-229, DO-18-230, DO-18-234).

Maple Gold Mines Ltd. (MGMLF), closed Monday's trading session at $0.08, up 3.56%, on 28,000 volume with 5 trades. The average volume for the last 3 months is 133,648 and the stock's 52-week low/high is $0.0698/$0.27.


Chesapeake Gold Corp. (CHPGF)

Stock Orange, 24hgold, Gold Stock Data, Penny Stock Hub, Capital Cube, Small Cap Network, Barchart, Investor Intel, Metals Channel, The Street, Stockhouse, Wallmine, YCharts, Mining Stock Valuator, Research Pool, Equities, OTC Markets, Silicon Investor, GuruFocus, Northern Miner, MarketWatch, StockInvest, Wallet Investor, Market Screener, Morningstar, Investors Hub, 4-Traders, and Investors Hangout reported on Chesapeake Gold Corp. (CHPGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Chesapeake Gold Corp. concentrates on the exploration and development of precious metals projects in North America. The Company’s management and technical team have an excellent track record. This team, with Francisco Gold Corp., discovered El Sauzal and Marlin, which are two Goldcorp, Inc. mines in Mexico and Guatemala. Chesapeake Gold’s shares trade on the OTC Markets Group’s OTCQX. The Company is based in Vancouver, British Columbia.

Chesapeake Gold's major project is its 100 percent owned Metates gold deposit This project is in Durango state, Mexico. Metates is one of the largest undeveloped gold and silver projects in the world. Independent Mining Consultants reported NI 43-101 (National Instrument 43-101) proven and probable reserves of 18.5 million ounces of gold, 526 million ounces of silver, and 4.2 billion pounds of zinc. The metal prices assumed for the reserves are $1,200 per ounce gold and $25 for silver per ounce at a cutoff grade of 0.35 g/t gold equivalent.

Metates has the option to be an initial 30,000 tpd or 60,000 tpd mine that expands to full nameplate capacity. A pre-feasibility study (PFS) by M3 Engineering indicates at the Phase 2 throughput rate of 120,000 tpd, annual production over 25 years would be 659,000 ounces of gold, 16 million ounces of silver and 143 million pounds of zinc at a gold equivalent cash cost of $490 per ounce, net zinc credits.

Chesapeake Gold’s Mexico properties also include Yarely, La Gitana, La Cecilia, and Tatatila. Yarely is an emerging diversified camp and drilling discovered a large porphyry system. The Company’s U.S. property is Talapoosa. Talapoosa has an open pit resource of 1.2 million ozs of gold and 16 million ozs silver with excellent exploration upside. Chesapeake’s Guatemala property is El Escorpion.

This past June, Chesapeake Gold provided an update on the results of the Phase 1 drilling program at the Company’s regional Yarely Project in Sinaloa State, Mexico. Yarely covers 72,000 hectares. It is strategically positioned 10 kilometers from a paved highway and within 25 kilometers of the proposed Metates plant site.

P. Randy Reifel, stated, "Although early stage, the Phase 1 drill campaign has confirmed that Yarely has the potential to be a diversified mineralized camp with district scale prospects. Drilling discovered a blind porphyry system from the geophysical survey at Loretos. A high grade silver-gold vein field and ore grade zinc-gold skarn-hosted mineralization have been identified at Central and Lucy. The geological and geophysical work to date suggests Yarely could host several porphyry type targets which would be the first known in this region of the country.”

Chesapeake Gold Corp. (CHPGF), closed Monday's trading session at $1.5877, even for the day. The average volume for the last 3 months is 7,700 and the stock's 52-week low/high is $1.29/$3.13.


Dyadic International, Inc. (DYAI)

Stockflare, MicroCapDaily, YCharts, Journal Transcript, Capital Cube, Stockhouse, Zacks, Street Insider, Equity Clock, GuruFocus, Proactive Investors, Investors Hub, MarketWatch, Morningstar, Corporate Connect, Market Screener, and Stockopedia reported on Dyadic International, Inc. (DYAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dyadic International, Inc. is a global biotechnology company listed on the OTCQX. Its emphasis is on further improving and applying its proprietary C1 gene expression platform to expedite the development and lessen the cost of biologic vaccines and drugs at flexible commercial scales. Dyadic International has its corporate headquarters in Jupiter, Florida. The Company has a foreign subsidiary, Dyadic Nederland, BV, which maintains a small satellite office in Wageningen, the Netherlands.

Dyadic International has developed a method for producing commercial quantities of enzymes and other proteins needed for the production of industrial enzymes. The Company has successfully licensed this technology to third parties including Abengoa Bioenergy, BASF, Codexis as well as others.

The foundation of the technology is on the Myceliophthora thermophila fungus, which Dyadic named C1.  The C1 technology is a strong and versatile fungal expression system for gene discovery, development, expression and production of enzymes and other proteins.

Dyadic International’s C1 Expression System is an optimized and industrially proven system. It turns genes into a wide range of valuable products.  The C1 Technology Platform helps to overcome some of the inadequacies of existing expression technologies used for gene discovery, product development and commercialization. Dyadic International is seeking research collaborations, government funding, partners, and sub-licensees in which to apply the C1 platform in the vaccine, antibody, biosimilar and biobetters industries.

In September, Dyadic International announced that it entered into a fully funded proof of concept research collaboration with Sanofi-Aventis Deutschland GmbH to explore the potential of its C1 technology to produce multiple kinds of biologic vaccines and drugs of interest for human health indications. Sanofi-Aventis Deutschland GmbH is a company of the Sanofi group, one of the world’s top tier biopharmaceutical enterprises.

With this agreement, Sanofi-Aventis will fund the collaborative research that will use the proprietary and patented C1 Gene Expression Platform Technology to express multiple genes for vaccine and drug applications. The expectation is that the research will be completed in the second half of 2019.

Dyadic International, Inc. (DYAI), closed Monday's trading session at $2.10, down 1.87%, on 257,300 volume with 257 trades. The average volume for the last 3 months is 54,309 and the stock's 52-week low/high is $1.35/$2.29.


Pacific Health Care Organization, Inc. (PFHO)

NetworkNewsWire, Amigo Bulls, Zacks, OTC Markets, The Street, Stockopedia, Simply Wall St, MarketWatch, Morningstar, Stockhouse, Market Exclusive, 4-Traders, InvestorsHub, last10k, CapitalCube, Business Insider, Infront Analytics, TradingView, Insider Tracking, Insider Monkey, Marketbeat, GuruFocus, and Information Vine reported on Pacific Health Care Organization, Inc. (PFHO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pacific Health Care Organization, Inc. via its subsidiaries, engages in managing and administering health care organizations (HCOs) and managed provider networks in the State of California. The Company specializes in workers’ compensation cost containment. Through its two HCOs, it offers injured workers a choice of enrolling in an HCO with a network managed by primary care providers requiring a referral to specialists; or a second HCO, where injured workers do not need any previous authorization to be seen and treated by specialists.

Incorporated in 1970, Pacific Health Care Organization has its head office in Newport Beach, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Pacific Health Care’s business goal is to deliver value to its clients that lessens their workers’ compensation related medical claims expense in a way that will assure that injured employees receive high quality healthcare, which allows them to recover from injury and return to gainful employment without excessive delay.

By way of its wholly-owned subsidiaries, the Company provides a range of effective workers’ compensation cost containment services. These include but are not limited to, Health Care Organizations, Medical Provider Networks, HCO + MPN, Workers’ Compensation Carve-Outs, Utilization Review, Medical Bill Review, Nurse Case Management, Lien Representation, Legal Support and Medicare Set Aside services.

Pacific Health Care Organization’s subsidiaries are Medex Health Care, Medex Managed Care, Medex Medical Management, Medex Legal Support, and IRC Industrial Resolutions Coalition.

In May, Pacific Health Care Organization reported financial results for the quarter ended March 31, 2018. It reported Total Revenue of $1,583,309 for the quarter ended March 31, 2018, versus Total Revenue of $1,541,256 for the quarter ended March 31, 2017.

Pacific Health Care reported Net Income of $399,681 or $0.12 per basic shares and $0.11 per fully diluted shares for Q1 2018, versus Net Income of $222,257 or $0.07 per basic and fully diluted shares for Q1 2017.

Pacific Health Care Organization, Inc. (PFHO), closed Monday's trading session at $5.85, up 0.86%, on 100 volume with 1 trade. The average volume for the last 3 months is 935 and the stock's 52-week low/high is $3.119/$5.949.


The QualityStocks Company Corner

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc.’s (OTCQB: ETST) anticipation that its pure hemp oil and new formulas will eventually be sold globally and that it will be a licensed distributor and will work closely with pharmacists and researchers to serve the cannabis market has been strengthened by the DEA’s recent decision on CBD (

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.80, up 21.62%, on 135,913 volume with 211 trades. The average volume for the last 3 months is 80,823 and the stock's 52-week low/high is $0.421/$2.45.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsAudio announces the Audio Press Release (APR) titled “Growth of Blockchain Provides Financial Services for Underserved Markets,” featuring SinglePoint, Inc. (OTCQB: SING). To hear the NetworkNewsAudio version, visit: To read the full editorial, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.03125, up 0.48%, on 2,488,317 volume with 156 trades. The average volume for the last 3 months is 4,128,882 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News


Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTC: STLHF), a lithium-focused exploration company, is ready for procurement and fabrication of its rapid lithium extraction demonstration plant. To view the full article, visit:

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.


Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $1.24, up 0.81%, on 44,897 volume with 29 trades. The average volume for the last 3 months is 45,269 and the stock's 52-week low/high is $0.604/$2.23.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

From Fox Business ( to The New York Times (, oil and gas company Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: A2DYWC) has been making headlines in a big way. What is all the buzz about? Petroteq has pioneered a sustainable and environmentally safe technology for extracting heavy oils from oil sands, oil shale deposits and shallow oil deposits—the first of its kind in the industry.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.86, even for the day, on 177,326 volume with 64 trades. The average volume for the last 3 months is 423,468 and the stock's 52-week low/high is $0.294/$1.889.

Recent News


Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Aiming to profit from the substantial commercial potential of gold, lithium and cobalt, Canada-based Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) remains diligent in its exploration of a metals-rich South American zone. To view the full article, visit:

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.10, even for the day, on 13,500 volume with 2 trades. The average volume for the last 3 months is 23,187 and the stock's 52-week low/high is $0.009/$0.165.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

It is just days before recreational cannabis becomes legal throughout Canada but difficulties are already shaping up regarding how this legalization will affect Canadians who wish to travel to the U.S. The Customs and Border Protection (CBP) service has confirmed that steps will be taken to bar people who are involved in the Canadian marijuana industry from entering the U.S. Canadian citizens are beginning to get a taste of what companies like VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) have to deal with, as they expand from one jurisdiction to another.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.08, off by 0.92%, on 269,557 volume with 236 trades. The average volume for the last 3 months is 632,151 and the stock's 52-week low/high is $0.73/$3.29.

Recent News



The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL), an internet-based search engine that gives cannabis users a responsive directory specialized to their need to find outlets with defined products, is continuing to roll out new features, including options that allow members to share comments on their results, as the company prepares to monetize its operations with new growth.

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $2.43, up 1.25%, on 343,698 volume with 462 trades. The average volume for the last 3 months is 183,366 and the stock's 52-week low/high is $0.405/$2.49.

Recent News


Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

CannabisNewsAudio announces the Audio Press Release (APR) titled “Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector,” featuring Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP). To hear the CannabisNewsAudio version, visit: To read the full editorial, visit: Also today, NetworkNewsWire released a report on the company detailing how LXRP is building its strategic intellectual property (“IP”) portfolio with two recent Notices of Allowance from the U.S. Patent and Trademark Office (“USPTO”) as well as the addition of three new patents in Australia. To view the full article, visit:

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.00, up 2.04%, on 162,801 volume with 214 trades. The average volume for the last 3 months is 214,303 and the stock's 52-week low/high is $0.3219/$2.539.

Recent News


Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is a Los Angeles-based firm offering a battery of services to help launch and grow emerging and existing cannabis brands. The company’s chief focus is acquiring, incubating, developing and partnering with startup and growth-stage companies in the cannabis industry, as well as ancillary sectors across the globe, providing them with capital, consulting services and other assistance to help them become category leaders in the cannabis market.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $2.97, off by 8.62%, on 42,705 volume with 123 trades. The average volume for the last 3 months is 103,284 and the stock's 52-week low/high is $0.0309/$7.13.

Recent News


Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) is among the ‘Top 100 Global Direct Selling Companies’. Along with unique services, Youngevity offers products from the top selling retail categories. These categories include health/nutrition, home/family, food/beverage, spa/beauty, fashion, essential oils and photo. The company distributes its products and services via a worldwide network of preferred customers and distributors. A foremost omni-direct lifestyle company, Youngevity International has its corporate headquarters in Chula Vista, California.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.12, off by 15.82%, on 198,882 volume with 946 trades. The average volume for the last 3 months is 76,596 and the stock's 52-week low/high is $3.167/$9.80.

Recent News


Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.3925, off by 1.38%, on 4,050 volume with 5 trades. The average volume for the last 3 months is 63,198 and the stock's 52-week low/high is $0.009/$0.50.

Recent News


Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0005, even for the day, on 8,387,783 volume with 11 trades. The average volume for the last 3 months is 17,166,398 and the stock's 52-week low/high is $0.0004/$0.0299.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.5011, off by 5.90%, on 10,170 volume with 11 trades. The average volume for the last 3 months is 44,407 and the stock's 52-week low/high is $0.4797/$0.97.

Recent News


Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.7738, off by 3.33%, on 10,851 volume with 21 trades. The average volume for the last 3 months is 18,854 and the stock's 52-week low/high is $2.44/$8.19.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.